Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Other financing activities (2016 - 2017)

Historic Other financing activities for Outlook Therapeutics (OTLK) over the last 2 years, with Q3 2017 value amounting to $176086.0.

  • Outlook Therapeutics' Other financing activities changed N/A to $176086.0 in Q3 2017 from the same period last year, while for Sep 2017 it was $216086.0, marking a year-over-year change of. This contributed to the annual value of $823894.0 for FY2023, which is 3731.57% up from last year.
  • Latest data reveals that Outlook Therapeutics reported Other financing activities of $176086.0 as of Q3 2017.
  • In the past 5 years, Outlook Therapeutics' Other financing activities registered a high of $176086.0 during Q3 2017, and its lowest value of $40000.0 during Q4 2016.